Cliff Asness's EVH Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 174,006 shares of Evolent Health, Inc. (EVH) worth $396,733, representing 0.00% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in EVH, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 171,010 shares. Largest reduction occurred in Q1 2021, reducing 61,566 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Evolent Health (EVH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Evolent Health (EVH) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -15,505 | Reduce 8.18% | 174,006 | $2.28 |
| Q4 2025 | +171,010 | Add 924.33% | 189,511 | $4.00 |
| Q3 2025 | -2,207 | Reduce 10.66% | 18,501 | $8.46 |
| Q2 2025 | +9,411 | Add 83.31% | 20,708 | $11.26 |
| Q1 2025 | -657 | Reduce 5.50% | 11,297 | $9.47 |
| Q4 2024 | +4,762 | Add 66.21% | 11,954 | $11.25 |
| Q3 2024 | +7,192 | New Buy | 7,192 | $28.28 |
| Q2 2024 | -6,977 | Sold Out | 0 | $0.00 |
| Q1 2024 | +234 | Add 3.47% | 6,977 | $32.79 |
| Q4 2023 | -4,411 | Reduce 39.55% | 6,743 | $33.03 |
| Q3 2023 | -10,890 | Reduce 49.40% | 11,154 | $27.23 |
| Q2 2023 | -925 | Reduce 4.03% | 22,044 | $30.30 |
| Q1 2023 | -54,806 | Reduce 70.47% | 22,969 | $32.45 |
| Q4 2022 | -7,827 | Reduce 9.14% | 77,775 | $28.08 |
| Q3 2022 | +22,402 | Add 35.45% | 85,602 | $35.93 |
| Q2 2022 | +12,734 | Add 25.23% | 63,200 | $30.71 |
| Q1 2022 | +13,383 | Add 36.09% | 50,466 | $32.30 |
| Q4 2021 | +1,995 | Add 5.69% | 37,083 | $27.67 |
| Q3 2021 | -1,676 | Reduce 4.56% | 35,088 | $31.01 |
| Q2 2021 | -5,306 | Reduce 12.61% | 36,764 | $21.11 |
| Q1 2021 | -61,566 | Reduce 59.41% | 42,070 | $20.20 |
| Q4 2020 | +85,059 | Add 457.87% | 103,636 | $16.03 |
| Q3 2020 | +18,577 | New Buy | 18,577 | $12.43 |
| Q1 2020 | -16,371 | Sold Out | 0 | $0.00 |
| Q4 2019 | +16,371 | New Buy | 16,371 | $9.04 |
| Q3 2019 | -10,609 | Sold Out | 0 | $0.00 |
| Q2 2019 | -16,314 | Reduce 60.60% | 10,609 | $7.92 |
| Q1 2019 | +427 | Add 1.61% | 26,923 | $12.59 |
| Q4 2018 | +26,496 | New Buy | 26,496 | $19.97 |
| Q3 2017 | -34,004 | Sold Out | 0 | $0.00 |
| Q2 2017 | +360 | Add 1.07% | 34,004 | $25.35 |
| Q1 2017 | +7,987 | Add 31.13% | 33,644 | $22.29 |
| Q4 2016 | +14,723 | Add 134.65% | 25,657 | $14.81 |
| Q3 2016 | +10,934 | New Buy | 10,934 | $24.60 |
Cliff Asness's Evolent Health Investment FAQs
Cliff Asness first purchased Evolent Health, Inc. (EVH) in Q3 2016, acquiring 10,934 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Evolent Health, Inc. (EVH) for 34 quarters since Q3 2016.
Cliff Asness's largest addition to Evolent Health, Inc. (EVH) was in Q4 2025, adding 189,511 shares worth $758,044.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 174,006 shares of Evolent Health, Inc. (EVH), valued at approximately $396,733.
As of the Q1 2026 filing, Evolent Health, Inc. (EVH) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Evolent Health, Inc. (EVH) was 189,511 shares, as reported at the end of Q4 2025.